US Stock MarketDetailed Quotes

IKNA Ikena Oncology

Watchlist
  • 1.310
  • +0.010+0.77%
Trading Apr 29 14:19 ET
63.22MMarket Cap-803P/E (TTM)

About Ikena Oncology Company

Ikena Oncology, Inc. is a clinical stage biotechnology company, which engages in the development of patient directed and biomarker driven therapies for cancer patients. Its product pipeline includes IK-930, RAS Signaling, IK-175, IK-412, and IK-007. The company was founded by Mark Manfredi and George Georgiou in February 2016 and is headquartered in Boston, MA.

Company Profile

SymbolIKNA
Company NameIkena Oncology
Listing DateMar 26, 2021
Issue Price16.00
Founded2016
CEODr. Mark Manfredi, PhD
MarketNASDAQ
Employees43
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address645 Summer Street,Suite 101
CityBoston
ProvinceMassachusetts
CountryUnited States of America
Zip Code02210
Phone1-857-273-8343
Websitehttp://www.ikenaoncology.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Mark Manfredi, PhD
  • President, Chief Executive Officer and Director
  • 2.46M
  • Xiaoyan Michelle Zhang
  • Chief Scientific Officer
  • --
  • Dr. Jeffrey Ecsedy, PhD
  • Chief Development Officer
  • --
  • Dr. Jotin Marango, M.D.,PhD
  • Chief Financial Officer, Head of Corporate Development and Principal Accounting Officer
  • 2.16M
  • Caroline Germa
  • Chief Medical Officer
  • --
  • Owen P. Hughes, Jr
  • Chairman of the Board
  • 71.95K
  • Dr. Otello Stampacchia, PhD
  • Independent Director
  • 96.49K
  • Dr. Jean-Francois Formela,M.D.
  • Independent Director
  • 93.49K
  • Dr. Iain D. Dukes, D.Phil.
  • Independent Director
  • 84.99K
  • Dr. David P. Bonita, M.D.
  • Independent Director
  • 94.99K
  • Dr. Maria Koehler, M.D.,PhD
  • Independent Director
  • 80.99K
  • Dr. Richard Wooster, PhD
  • Independent Director
  • 307.87K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg